Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Vigilância Sanitária em Debate |
Texto Completo: | https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002 |
Resumo: | Introduction: Scientific production has experienced an unprecedented increase with the COVID-19 pandemic in a short period of time. Objective: To identify and characterize the Latin American scientific production on anotechnology-based products with potential applications in the areas of diagnosis, vaccine, pharmacological treatment, theranostics and non-pharmacological intervention to fight COVID-19. Method: A scoping review was conducted based on the framework of Arksey and O’Malley and sought to incorporate recommendations from the Joanna Briggs Institute Reviewer’s Manual and Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). The bibliographic search took place in PubMed, Science Direct, LILACS and SciELO. Studies that reported nanotechnology-based products with potential applications in the areas of interest referenced previously were included. A simple quantitative analysis was conducted to provide numerical summaries of characteristics of interest from the studies added to the review. Results: 26 (3.4%) articles published in 14 international and regional journals were included. Authors from five countries (Brazil, Chile, Costa Rica, Ecuador, and Mexico) were responsible for the total number of articles that made up the review. The production of 6 (23.1%) articles included international collaboration, involving institutions from 10 countries. The median time from submission to publication of articles was 126 days (interquartile range: 58–200). Most of the Latin American scientific production consisted of narrative reviews (n = 19; 73.1%). The five areas defined as of interest for this study were addressed by one of the scientific articles, especially the products intended for pharmacological treatment of COVID-19 (n = 14; 53.8%). Conclusions: This is the first scoping review to provide a map of Latin American scientific production on nanotechnology-based products with potential applications in areas of interest to fight COVID-19. There are deficiencies related to the publication of basic research, representativeness of Latin American countries in the region, studies with greater strength of evidence and to international collaboration to produce scientific articles that merit to be reduced. |
id |
FIOCRUZ-9_2efa46c1c61259c131955f0c52498385 |
---|---|
oai_identifier_str |
oai:ojs.visaemdebate.incqs.fiocruz.br:article/2002 |
network_acronym_str |
FIOCRUZ-9 |
network_name_str |
Vigilância Sanitária em Debate |
repository_id_str |
|
spelling |
Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023Produção científica latino-americana sobre produtos à base de nanotecnologia para o enfrentamento da COVID-19: uma revisão de escopo: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Publicado em: 27/02/2023 COVID-19Infecções por CoronavirusNanomedicinaNanotecnologiaRevisão de EscopoNanotecnologiaCOVID-19Coronavirus InfectionsNanomedicineNanotechnologyScoping ReviewIntroduction: Scientific production has experienced an unprecedented increase with the COVID-19 pandemic in a short period of time. Objective: To identify and characterize the Latin American scientific production on anotechnology-based products with potential applications in the areas of diagnosis, vaccine, pharmacological treatment, theranostics and non-pharmacological intervention to fight COVID-19. Method: A scoping review was conducted based on the framework of Arksey and O’Malley and sought to incorporate recommendations from the Joanna Briggs Institute Reviewer’s Manual and Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). The bibliographic search took place in PubMed, Science Direct, LILACS and SciELO. Studies that reported nanotechnology-based products with potential applications in the areas of interest referenced previously were included. A simple quantitative analysis was conducted to provide numerical summaries of characteristics of interest from the studies added to the review. Results: 26 (3.4%) articles published in 14 international and regional journals were included. Authors from five countries (Brazil, Chile, Costa Rica, Ecuador, and Mexico) were responsible for the total number of articles that made up the review. The production of 6 (23.1%) articles included international collaboration, involving institutions from 10 countries. The median time from submission to publication of articles was 126 days (interquartile range: 58–200). Most of the Latin American scientific production consisted of narrative reviews (n = 19; 73.1%). The five areas defined as of interest for this study were addressed by one of the scientific articles, especially the products intended for pharmacological treatment of COVID-19 (n = 14; 53.8%). Conclusions: This is the first scoping review to provide a map of Latin American scientific production on nanotechnology-based products with potential applications in areas of interest to fight COVID-19. There are deficiencies related to the publication of basic research, representativeness of Latin American countries in the region, studies with greater strength of evidence and to international collaboration to produce scientific articles that merit to be reduced.Introdução: A produção científica tem experimentado um aumento sem precedentes com a pandemia de COVID-19 em um curto espaço de tempo. Objetivo: Identificar e caracterizar a produção científica latino-americana sobre produtos à base de nanotecnologia com potenciais aplicações nas áreas de diagnóstico, vacina, tratamento farmacológico, teranóstico e intervenção não farmacológica para o enfrentamento da COVID-19. Método: Uma revisão de escopo foi conduzida com base na estrutura de Arksey e O’Malley e buscou incorporar recomendações do Joanna Briggs Institute Reviewer’s Manual e do Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). A busca bibliográfica ocorreu na PubMed, Science Direct, LILACS e SciELO. Estudos que relataram produtos à base de nanotecnologia com potenciais aplicações nas áreas de interesse referenciadas anteriormente foram incluídos. Uma análise quantitativa simples foi conduzida para fornecer resumos numéricos das características de interesse dos estudos adicionados na revisão. Resultados: Foram incluídos 26 (3,4%) artigos publicados em 14 revistas internacionais e regionais. Autores de cinco países (Brasil, Chile, Costa Rica, Equador e México) foram responsáveis pelos artigos que compuseram a revisão. A colaboração internacional ocorreu para a produção de seis (23,1%) artigos, envolvendoinstituições de dez países. O tempo mediano do envio à publicação dos artigos foi de 126 dias (intervalo interquartil: 58–200). A maior parte da produção científica latinoamericana foi de revisões narrativas (n = 19; 73,1%). As cinco áreas definidas como de interesse deste estudo foram abordadas por algum dos artigos científicos, com destaque para os produtos destinados ao tratamento farmacológico da COVID-19 (n = 14; 53,8%). Conclusões: Esta é a primeira revisão de escopo a fornecer um mapa da produção científica latino-americana sobre produtos à base de nanotecnologia com potenciais aplicações em áreas de interesse para o enfrentamento da COVID-19. Existem deficiências relativas à publicação de pesquisa básica, representatividade de países da América Latina, estudos com maior força de evidência e colaboração internacional para a produção de artigos científicos que merecem ser reduzidas.Instituto Nacional de Controle de Qualidade em Saúde2023-02-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/200210.22239/2317-269x.02002Health Surveillance under Debate: Society, Science & Technology ; v. 11 (2023) | Continuous publication; 1-12Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; v. 11 (2023) | Publicación continua; 1-12Vigil Sanit Debate, Rio de Janeiro; v. 11 (2023) | Publicação contínua; 1-122317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporenghttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1485https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1590https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1526https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1527https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1528Copyright (c) 2023 Daniel Marques Mota, Paulo José Gonçalves Ferreira, Fabian Teixeira Primo (Autor)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMota, Daniel MarquesGonçalves Ferreira, Paulo JoséTeixeira Primo, Fabian2024-02-21T17:53:10Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/2002Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2024-02-21T17:53:10Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.none.fl_str_mv |
Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023 Produção científica latino-americana sobre produtos à base de nanotecnologia para o enfrentamento da COVID-19: uma revisão de escopo: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Publicado em: 27/02/2023 |
title |
Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023 |
spellingShingle |
Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023 Mota, Daniel Marques COVID-19 Infecções por Coronavirus Nanomedicina Nanotecnologia Revisão de Escopo Nanotecnologia COVID-19 Coronavirus Infections Nanomedicine Nanotechnology Scoping Review |
title_short |
Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023 |
title_full |
Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023 |
title_fullStr |
Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023 |
title_full_unstemmed |
Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023 |
title_sort |
Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023 |
author |
Mota, Daniel Marques |
author_facet |
Mota, Daniel Marques Gonçalves Ferreira, Paulo José Teixeira Primo, Fabian |
author_role |
author |
author2 |
Gonçalves Ferreira, Paulo José Teixeira Primo, Fabian |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Mota, Daniel Marques Gonçalves Ferreira, Paulo José Teixeira Primo, Fabian |
dc.subject.por.fl_str_mv |
COVID-19 Infecções por Coronavirus Nanomedicina Nanotecnologia Revisão de Escopo Nanotecnologia COVID-19 Coronavirus Infections Nanomedicine Nanotechnology Scoping Review |
topic |
COVID-19 Infecções por Coronavirus Nanomedicina Nanotecnologia Revisão de Escopo Nanotecnologia COVID-19 Coronavirus Infections Nanomedicine Nanotechnology Scoping Review |
description |
Introduction: Scientific production has experienced an unprecedented increase with the COVID-19 pandemic in a short period of time. Objective: To identify and characterize the Latin American scientific production on anotechnology-based products with potential applications in the areas of diagnosis, vaccine, pharmacological treatment, theranostics and non-pharmacological intervention to fight COVID-19. Method: A scoping review was conducted based on the framework of Arksey and O’Malley and sought to incorporate recommendations from the Joanna Briggs Institute Reviewer’s Manual and Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). The bibliographic search took place in PubMed, Science Direct, LILACS and SciELO. Studies that reported nanotechnology-based products with potential applications in the areas of interest referenced previously were included. A simple quantitative analysis was conducted to provide numerical summaries of characteristics of interest from the studies added to the review. Results: 26 (3.4%) articles published in 14 international and regional journals were included. Authors from five countries (Brazil, Chile, Costa Rica, Ecuador, and Mexico) were responsible for the total number of articles that made up the review. The production of 6 (23.1%) articles included international collaboration, involving institutions from 10 countries. The median time from submission to publication of articles was 126 days (interquartile range: 58–200). Most of the Latin American scientific production consisted of narrative reviews (n = 19; 73.1%). The five areas defined as of interest for this study were addressed by one of the scientific articles, especially the products intended for pharmacological treatment of COVID-19 (n = 14; 53.8%). Conclusions: This is the first scoping review to provide a map of Latin American scientific production on nanotechnology-based products with potential applications in areas of interest to fight COVID-19. There are deficiencies related to the publication of basic research, representativeness of Latin American countries in the region, studies with greater strength of evidence and to international collaboration to produce scientific articles that merit to be reduced. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-02-27 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion "Peer-reviewed article" "Artículo revisado por pares" "Artigo avaliado pelos pares" |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002 10.22239/2317-269x.02002 |
url |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002 |
identifier_str_mv |
10.22239/2317-269x.02002 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1485 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1590 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1526 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1527 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1528 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
dc.source.none.fl_str_mv |
Health Surveillance under Debate: Society, Science & Technology ; v. 11 (2023) | Continuous publication; 1-12 Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; v. 11 (2023) | Publicación continua; 1-12 Vigil Sanit Debate, Rio de Janeiro; v. 11 (2023) | Publicação contínua; 1-12 2317-269X reponame:Vigilância Sanitária em Debate instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Vigilância Sanitária em Debate |
collection |
Vigilância Sanitária em Debate |
repository.name.fl_str_mv |
Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br |
_version_ |
1797042046628790272 |